Since STAT3, a downstream target of COX2/PGE2, is involved in the regulation of primitive CK14+ cell expansion [47], we propose that in bladder cancer metformin inhibits CK14+ cell repopulation through the COX2/PGE2/STAT3 axis. Here, KRT14 is linked to urinary bladder cancer.